Definitive Contract 75N91022C00055

Award Date 9/16/22
Potential Completion Date 12/15/23
Potential Value $396K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,980,915.00 firm-fixed-price SBIR Phase II contract awarded by the National Cancer Institute (part of the Department of Health and Human Services) to Pyramid Technical Consultants, Inc., a for-profit manufacturing company, for the development of ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract has a period of performance from September 16, 2024 to September 15, 2026 and is set aside for a small business. The contract was awarded under SBIR Topic 434...
This is a $398,714 firm fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Irai Technologies, LLC, a minority-owned small business. The contract is for the development of a flash dosimetry system based on ionizing radiation acoustic imaging, under Solicitation PHS-2023-1 for the NIH and CDC SBIR program. The goal is to contribute toward NCI mission needs and SBIR program objectives by stimulating technological innovation and fostering participation from small,...
This $397,626 Firm Fixed Price contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Standard Imaging Inc., a small business manufacturer of radiation measurement equipment and software headquartered in Middleton, Wisconsin. The award is for the development of "A Novel Scintillation Detector System for Flash Radiation Therapy" under the NCI's Small Business Innovation Research (SBIR) program. This SBIR contract...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
This $399,617 Firm Fixed Price contract was awarded by the National Cancer Institute (NCI) to Tibaray, Inc., a Bay Area startup that develops particle accelerator systems for cancer treatment. The contract, which is set aside for small businesses, is part of the NCI's Small Business Innovation Research (SBIR) program and funds research and development of ultra-fast dose rate (FLASH) radiation detectors and safety systems. Tibaray, a manufacturer of medical equipment, has previously received...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a civilian agency, to Tetraimaging, a for-profit manufacturer, for the development of a key component of the Tetrahedron Beam Computed Tomography (TBCT) system. The TBCT system is an innovative x-ray imaging technology with improved mobility, speed, image quality, and reduced cost, which can be used for both image-guided interventions and mobile diagnostic CT scanning. The purpose of...
This is a $454,997 fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Ambay Immune Sensors And Controls, LLC, a woman-owned small business. The contract was awarded under the FY20 SBIR Phase I solicitation and is for the development of a "non-invasive, novel test to monitor biological response to radiotherapy" under Topic #400 - AMBAY RADI-SENSE. The contract...
This $1,999,956.00 firm fixed-price Small Business Innovation Research (SBIR) Phase II contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Tibaray, Inc. - a Bay Area startup that develops particle accelerator systems for cancer treatment. The contract supports the topic "ULTRA-RAID RF-BASED BEAM MONITOR FOR REAL-TIME FLASH BEAM CONTROL" and has a performance period running through September 15, 2026. Tibaray...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader...

This is a $396,190 firm fixed price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Tetraimaging LLC, a small disadvantaged business, to develop ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract was awarded on September 16, 2022 and is set to complete by December 15, 2023. The original solicitation, PHS-2022-1, announced by the NIH and CDC, sought small business proposals to advance their missions in areas such as infectious disease, cancer, aging, and public health through research and development.

Generated 6/22/24, 9:27 AM